PARP inhibitors are a new area in the treatment of breast cancer

The paper considers the use of poly(ADP-ribose)-polymerase inhibitors in therapy for breast and ovarian cancer. Particular attention is given to drugs, such as olaparib and BSI-201. It is noted that the emergence of drugs of this class, of course, holds great promise for using remedial measures and...

Full description

Bibliographic Details
Main Author: V. P. Letyagin
Format: Article
Language:Russian
Published: ABV-press 2014-08-01
Series:Опухоли женской репродуктивной системы
Subjects:
Online Access:https://ojrs.abvpress.ru/ojrs/article/view/260
_version_ 1797876065701462016
author V. P. Letyagin
author_facet V. P. Letyagin
author_sort V. P. Letyagin
collection DOAJ
description The paper considers the use of poly(ADP-ribose)-polymerase inhibitors in therapy for breast and ovarian cancer. Particular attention is given to drugs, such as olaparib and BSI-201. It is noted that the emergence of drugs of this class, of course, holds great promise for using remedial measures and gives certain hopes for their optimization.
first_indexed 2024-04-10T01:57:29Z
format Article
id doaj.art-4dd25e895d1549ad8b1b210fd876db64
institution Directory Open Access Journal
issn 1994-4098
1999-8627
language Russian
last_indexed 2024-04-10T01:57:29Z
publishDate 2014-08-01
publisher ABV-press
record_format Article
series Опухоли женской репродуктивной системы
spelling doaj.art-4dd25e895d1549ad8b1b210fd876db642023-03-13T08:44:33ZrusABV-pressОпухоли женской репродуктивной системы1994-40981999-86272014-08-01044510.17650/1994-4098-2010-0-4-4-5276PARP inhibitors are a new area in the treatment of breast cancerV. P. Letyagin0ГУ РОНЦ им. Н.Н. Блохина РАМН, МоскваThe paper considers the use of poly(ADP-ribose)-polymerase inhibitors in therapy for breast and ovarian cancer. Particular attention is given to drugs, such as olaparib and BSI-201. It is noted that the emergence of drugs of this class, of course, holds great promise for using remedial measures and gives certain hopes for their optimization.https://ojrs.abvpress.ru/ojrs/article/view/260апоптозингибиторы поли(адф-рибоза)-полимеразыолапарибbsi-201
spellingShingle V. P. Letyagin
PARP inhibitors are a new area in the treatment of breast cancer
Опухоли женской репродуктивной системы
апоптоз
ингибиторы поли(адф-рибоза)-полимеразы
олапариб
bsi-201
title PARP inhibitors are a new area in the treatment of breast cancer
title_full PARP inhibitors are a new area in the treatment of breast cancer
title_fullStr PARP inhibitors are a new area in the treatment of breast cancer
title_full_unstemmed PARP inhibitors are a new area in the treatment of breast cancer
title_short PARP inhibitors are a new area in the treatment of breast cancer
title_sort parp inhibitors are a new area in the treatment of breast cancer
topic апоптоз
ингибиторы поли(адф-рибоза)-полимеразы
олапариб
bsi-201
url https://ojrs.abvpress.ru/ojrs/article/view/260
work_keys_str_mv AT vpletyagin parpinhibitorsareanewareainthetreatmentofbreastcancer